Cutting-edge cancer centre to open in Australia 17 December 2010 German company Fresenius Kabi will open a $3.5 million oncology compounding centre in Brisbane, in the New Year. The state-of-the-art centre, located at Geebung, will employ more than 20 people and supply vital chemotherapy drugs and other specialised intravenous products to Queensland hospitals and clinics. Known as the Brisbane Oncology Compounding Centre, it will supply up to 200,000 units of oncology preparations each year - subject to the approval of its licence by the Therapeutic Goods Administration. Fresenius Kabi is installing world-leading, automated technology known as Robotic Intravenous Automation that will bring a new level of dose accuracy and patient safety to the compounding process. Fresenius Kabi Executive Vice President, South Asia Pacific, Nicolas Shortis said the centre would put Australia at the global forefront in innovative delivery of infusion technology. “We are delighted with the progress of construction and fit out of the new facility and the benefits it will bring to both our operations and the Queensland health system,” Mr Shortis said. “Fresenius Kabi currently services more than 15 hospitals in Queensland through a Queensland Health contract, and has an agreement to provide a compounded oncology service to Ramsay Health hospitals nationally. “We look forward to significantly expanding this service with the new Brisbane oncology centre,” he said. The investment success was supported by Trade and Investment Queensland and the Australian Trade Commission – Austrade. Austrade has worked with the company for several years and helped it to explore new business opportunities in Australia. Austrade Frankfurt Investment Manager, Simone Greulich said, “We’re pleased the company is expanding in Queensland. This successful project will contribute to further development of this industry sector and reflects Austrade’s focus on attracting and supporting innovative products and technologies.” Fresenius Kabi already employs more than 220 people in Australia through its South Asia Pacific head office in Sydney. More information |